Tower Research Capital LLC (Trc) Reata Pharmaceuticals Inc Transaction History

Tower Research Capital LLC (Trc)

$3.68 Billion
Q3 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$79.22 - $105.37 $69,159 - $91,988	873 Added 114.87%	1,633 $166,000
Q1 2023 May 09, 2023	BUY	$30.85 - $93.17 $10,087 - $30,466	327 Added 75.52%	760 $69,000
Q4 2022 Feb 10, 2023	SELL	$22.15 - $42.11 $54,223 - $103,085	-2,448 Reduced 84.97%	433 $16,000
Q3 2022 Nov 10, 2022	BUY	$19.41 - $36.49 $35,714 - $67,141	1,840 Added 176.75%	2,881 $72,000
Q2 2022 Aug 15, 2022	SELL	$20.71 - $36.5 $178,830 - $315,177	-8,635 Reduced 89.24%	1,041 $32,000
Q1 2022 May 12, 2022	BUY	$24.12 - $39.6 $175,665 - $288,406	7,283 Added 304.35%	9,676 $317,000
Q4 2021 Feb 14, 2022	BUY	$25.61 - $110.96 $50,554 - $219,035	1,974 Added 471.12%	2,393 $63,000
Q3 2021 Nov 15, 2021	SELL	$100.0 - $143.02 $89,200 - $127,573	-892 Reduced 68.04%	419 $42,000
Q2 2021 Aug 16, 2021	BUY	$78.27 - $151.29 $58,624 - $113,316	749 Added 133.27%	1,311 $185,000
Q1 2021 May 17, 2021	BUY	$94.25 - $132.81 $1,225 - $1,726	13 Added 2.37%	562 $56,000
Q4 2020 Feb 16, 2021	SELL	$102.03 - $184.62 $58,361 - $105,602	-572 Reduced 51.03%	549 $68,000
Q3 2020 Nov 16, 2020	SELL	$93.53 - $163.34 $263,286 - $459,802	-2,815 Reduced 71.52%	1,121 $109,000
Q2 2020 Aug 13, 2020	BUY	$126.3 - $176.56 $166,589 - $232,882	1,319 Added 50.4%	3,936 $614,000
Q1 2020 May 15, 2020	BUY	$124.16 - $247.74 $324,926 - $648,335	2,617 New	2,617 $378,000
Q4 2019 Feb 07, 2020	SELL	$74.57 - $217.92 $40,640 - $118,766	-545 Closed	0 $0
Q3 2019 Nov 05, 2019	BUY	$71.26 - $95.75 $36,556 - $49,119	513 Added 1603.13%	545 $44,000
Q2 2019 Aug 13, 2019	BUY	$77.72 - $94.35 $2,487 - $3,019	32 New	32 $3,000
Q1 2019 May 14, 2019	SELL	$51.9 - $101.79 $5,293 - $10,382	-102 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$48.76 - $76.44 $63,192 - $99,066	-1,296 Reduced 92.7%	102 $6,000
Q3 2018 Nov 13, 2018	BUY	$35.64 - $92.06 $36,602 - $94,545	1,027 Added 276.82%	1,398 $114,000
Q2 2018 Aug 15, 2018	BUY	$19.94 - $40.96 $7,397 - $15,196	371 New	371 $13,000
Q1 2018 May 15, 2018	SELL	$20.0 - $30.19 $55,420 - $83,656	-2,771 Closed	0 $0
Q4 2017 Feb 09, 2018	BUY	$22.39 - $33.27 $32,241 - $47,908	1,440 Added 108.19%	2,771 $78,000
Q3 2017 Nov 14, 2017	BUY	$26.29 - $31.88 $34,991 - $42,432	1,331	1,331 $41,000

Others Institutions Holding RETA

# of Institutions

Shares Held

62.7K

Call Options Held

Put Options Held

View Full List

About REATA PHARMACEUTICALS INC

Ticker RETA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,583,200
Description
Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...

More about RETA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account